Paladin received rights to commercialize Silenor in Canada, South America and Africa from Somaxon Pharmaceuticals, Inc. (NASDAQ:SOMX) in June 2011. Somaxon was purchased by Pernix Therapeutic Holdings, Inc. (PTX) in March …
CLEVELAND, Dec. 14, 2012 (CRWENewswire)-- The Sherwin-Williams Company (NYSE:SHW) will issue a press release announcing its financial results for the fourth quarter and year ended December 31, 2012 prior to the opening of the …